Optimize Binding Strength, No Libraries Required

Improving the affinity of your leads is necessary for unlocking their full potential and advancing to preclinical studies. 

Twist Biopharma Solutions’ next-generation artificial intelligence (AI) platform can direct the affinity maturation of antibody leads without the need for custom library generation. Along with our in silico humanization and a suite of Twist Antibody Optimization (TAO) platforms, our affinity maturation capabilities can reduce the typical workflows from months to weeks.